Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Core Laboratories Inc.

TD Cowen analyst Shaul Eyal reiterated a Buy rating on Cellebrite DI today and set a price target of $23.00. According to TipRanks, Eyal is a 5-sta...

Cellebrite DI (CLBT) Gets a Buy from TD Cowen

Celebrus Technologies ( ($GB:CLBS) ) has provided an update. Celebrus Technologies has repurchased 100,000 of its own ordinary shares at a volume-w...

Celebrus Technologies Buys Back 100,000 Shares, Updates Voting Rights

New activity is brewing for Columbia Financial ( ($CLBK) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder...

Columbia Financial to Fully Demutualize and Acquire Northfield Bancorp in Stock Offering-Backed Deal

Needham analyst Mike Cikos maintained a Buy rating on Cellebrite DI today and set a price target of $15.00. According to TipRanks, Cikos is a 4-sta...

Needham Remains a Buy on Cellebrite DI (CLBT)

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Cellebrite DI (CLBT), Ondas (ONDS) and BK Technologi...

Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), Ondas (ONDS)

Cellebrite DI ( ($CLBT) ) just unveiled an update. On May 14, 2026, Cellebrite reported first-quarter 2026 results showing revenue of $128.3 millio...

Cellebrite Posts Strong Q1 2026 Growth, Expands AI and Drone Forensics Portfolio

The latest announcement is out from Core Laboratories ( ($CLB) ). Core Laboratories Inc. held its Annual Meeting of Shareholders on May 12, 2026, i...

Core Laboratories Shareholders Back Directors, Auditor and Pay

Columbia Financial ( ($CLBK) ) has provided an update. On May 11, 2026, Columbia Financial, Inc. announced that a newly formed Maryland corporation...

Market Cap	$626.91M	P/E Ratio	23.09
52W High	$20.36	52W Low	$9.72
Div Yield	4.0%	Payout Ratio	6.4%
EPS Growth 3Y	15.7%	52W Position	30.2%
Overall Score	44	Value Score	80
Quality Score	42	Technical Score	10

EPS Current Est	$0.56	EPS Next Est	$0.82
EPS Growth Est	+46.4%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLB	$12.93	-5.34%	372.79K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLB	$12.93	-5.3%	372.79K
3
4
5
6

CLB

CLB

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Core Laboratories Inc. Data in Excel

Get Core Laboratories Inc. Data in Excel